Company / R&D per Share
Steris R&D per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.09
FY2024
5-year range
$1.02 / $1.15
FY2020-FY2024
Trend
+5.3%
vs FY2023
Sector context
#67 of 103
Health Care
What the data says
At $1.09, Steris's r&d per share ranks #67 of 103 in the Health Care sector. Declined from $1.15 to $1.09 over the past 2 years.
Based on SEC 10-K filings.
1.09 in FY2024 with a 5-year CAGR of +7.1%.
Declined from $1.15 to $1.09 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +2.3%
- 5-Year CAGR
- +7.1%
- 10-Year CAGR
- -
Sector benchmark
#67 of 103 in Health CareTop 65% of 103This company $1.09 Sector average $2.13
▼
-48.8% below sector average
Key checks
Key Insights
- In FY2024, r&d per share increased 5.3% year-over-year.
- Ranks #67 out of 103 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.09 | +5.3% |
| FY2023 | $1.04 | -10.2% |
| FY2022 | $1.15 | +13.1% |
| FY2021 | $1.02 | +30.0% |
| FY2020 | $0.78 | +1.5% |
| FY2019 | $0.77 | +4.9% |
| FY2018 | $0.74 | - |
| FY2017 | - | - |
| FY2016 | $0.69 | - |
As of FY2024 · SEC 10-K · Updated Mar 13, 2026